9-aminocamptothecin has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brumfield, A; Dookeran, KA; Rubin, JT | 1 |
Houghton, PJ; Stewart, CF; Thompson, J | 1 |
Chuang, N; Cohen, HW; O'Leary, JJ; Potmesil, M; Ren, CJ; Shapiro, RL | 1 |
Beran, M; Jeha, S; Kantarjian, H; O'Brien, S; Vitek, L | 1 |
1 review(s) available for 9-aminocamptothecin and Disease Models, Animal
Article | Year |
---|---|
Animal models for studying the action of topoisomerase I targeted drugs.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Disease Models, Animal; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms, Experimental; Rodentia; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1998 |
3 other study(ies) available for 9-aminocamptothecin and Disease Models, Animal
Article | Year |
---|---|
A comparison of locoregional depot and systemic preparations of 9-aminocamptothecin for treatment of liver metastases in a rat tumor model: superior antitumor activity of sustained-release preparation.
Topics: Animals; Antineoplastic Agents; Camptothecin; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Ethiodized Oil; Liver Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1997 |
Antiangiogenic effects of camptothecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cornea; Disease Models, Animal; Fibroblast Growth Factor 2; Irinotecan; Mice; Mice, Inbred Strains; Neovascularization, Pathologic; Neovascularization, Physiologic; Topotecan; Vincristine | 1999 |
Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia.
Topics: Acute Disease; Administration, Oral; Animals; Camptothecin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; HLA-DQ alpha-Chains; HLA-DQ Antigens; Humans; Injections, Intravenous; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mice, SCID; Neoplasm Transplantation; Survival Rate | 1998 |